Table: Taiko Pharmaceutical -2023 group results

Taiko Pharmaceutical

09/02/2024 06:30

Feb 9 (Reuters)- 
          Taiko Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended       Year ended       Year to       NEXT   
              Dec 31, 2023     Dec 31, 2022   Dec 31, 2024     YEAR     
                 LATEST          YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS        FORECAST    H1 FORECAST 
  Sales           6.12             5.04           6.80                  
               (+21.4 pct)                     (+11.1 pct)              
  Operating     loss 1.01       loss 3.08        410 mln                
  Recurring     loss 1.25       loss 3.35        360 mln                
  Net
  Net           loss 3.61       loss 4.90        350 mln                
  EPS        loss 76.25 yen  loss 112.26 yen    6.98 yen                
  Ann Div          NIL             NIL                                  
  -Q2 Div          NIL             NIL                                  
  -Q4 Div          NIL             NIL                                  
  
  NOTE - Taiko Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T